BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paprottka KJ, Schoeppe F, Ingrisch M, Rübenthaler J, Sommer NN, De Toni E, Ilhan H, Zacherl M, Todica A, Paprottka PM. Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients. Eur J Nucl Med Mol Imaging 2017;44:1185-93. [PMID: 28197686 DOI: 10.1007/s00259-017-3646-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Paprottka KJ, Galiè F, Ingrisch M, Geith T, Ilhan H, Todica A, Michl M, Nadjiri J, Paprottka PM. Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma-An Evaluation of Predictors. Cancers (Basel) 2021;13:5399. [PMID: 34771563 DOI: 10.3390/cancers13215399] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Depalo T, Traino AC, Bargellini I, Lorenzoni G, Bozzi E, Vivaldi C, Lamastra R, Masi G, Cioni R, Boni G, Volterrani D. Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres. Sci Rep 2021;11:19745. [PMID: 34611210 DOI: 10.1038/s41598-021-99219-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Shah RM, Sheikh S, Shah J, Vivian E, Mejia A, Shahin I, Mantry PS. Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single center. J Gastrointest Oncol 2021;12:1718-31. [PMID: 34532122 DOI: 10.21037/jgo-20-435] [Reference Citation Analysis]
4 Fabritius MP, Seidensticker M, Rueckel J, Heinze C, Pech M, Paprottka KJ, Paprottka PM, Topalis J, Bender A, Ricke J, Mittermeier A, Ingrisch M. Bi-Centric Independent Validation of Outcome Prediction after Radioembolization of Primary and Secondary Liver Cancer. J Clin Med 2021;10:3668. [PMID: 34441964 DOI: 10.3390/jcm10163668] [Reference Citation Analysis]
5 Ridouani F, Soliman MM, England RW, Hsu M, Moskowitz CS, Doustaly R, Sofocleous CT, Boas FE, Yarmohammadi H, Deipolyi AR. Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer. Eur J Radiol 2021;136:109539. [PMID: 33476965 DOI: 10.1016/j.ejrad.2021.109539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Masthoff M, Schindler P, Harders F, Heindel W, Wilms C, Schmidt HH, Pascher A, Stegger L, Rahbar K, Wildgruber M, Köhler M. Repeated radioembolization in advanced liver cancer. Ann Transl Med 2020;8:1055. [PMID: 33145274 DOI: 10.21037/atm-20-2658] [Reference Citation Analysis]
7 van Roekel C, Jongen JMJ, Smits MLJ, Elias SG, Koopman M, Kranenburg O, Borel Rinkes IHM, Lam MGEH. Mode of progression after radioembolization in patients with colorectal cancer liver metastases. EJNMMI Res 2020;10:107. [PMID: 32960390 DOI: 10.1186/s13550-020-00697-z] [Reference Citation Analysis]
8 Barat M, Cottereau AS, Kedra A, Dermine S, Palmieri LJ, Coriat R, Dautry R, Tselikas L, Soyer P, Dohan A. The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review. J Clin Med 2020;9:E2302. [PMID: 32698459 DOI: 10.3390/jcm9072302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Yammine K, Kamar F, Nasser J, Tayar C, Ghosn M, Chehade F, Daher J, Nicolas G. Single-Institution Experience with Selective Internal Radiation Therapy (SIRT) for the Treatment of Primary and Secondary Hepatic Tumors. Cureus. [DOI: 10.7759/cureus.7628] [Reference Citation Analysis]
10 Faron A, Sprinkart AM, Pieper CC, Kuetting DLR, Fimmers R, Block W, Meyer C, Thomas D, Attenberger U, Luetkens JA. Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area. Eur J Radiol 2020;125:108889. [PMID: 32087468 DOI: 10.1016/j.ejrad.2020.108889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
11 Zhen Y, Liu B, Chang Z, Ren H, Liu Z, Zheng J. A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma. Onco Targets Ther 2019;12:4489-98. [PMID: 31239717 DOI: 10.2147/OTT.S202875] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Galiè F, Paprottka KJ, Ingrisch M, Todica A, Ilhan H, Michl M, Geith T, Fabritius M, De Toni E, Paprottka PM. Impact of Baseline Cholinesterase in Patients with Primary Liver Tumors Undergoing Radioembolization: Impact on Outcome. SN Compr Clin Med 2019;1:85-92. [DOI: 10.1007/s42399-018-0029-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Gangi A, Shah J, Hatfield N, Smith J, Sweeney J, Choi J, El-Haddad G, Biebel B, Parikh N, Arslan B, Hoffe SE, Frakes JM, Springett GM, Anaya DA, Malafa M, Chen DT, Chen Y, Kim RD, Shridhar R, Kis B. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study. J Vasc Interv Radiol 2018;29:1101-8. [PMID: 30042074 DOI: 10.1016/j.jvir.2018.04.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
14 Ingrisch M, Schöppe F, Paprottka K, Fabritius M, Strobl FF, De Toni EN, Ilhan H, Todica A, Michl M, Paprottka PM. Prediction of 90Y Radioembolization Outcome from Pretherapeutic Factors with Random Survival Forests. J Nucl Med 2018;59:769-73. [PMID: 29146692 DOI: 10.2967/jnumed.117.200758] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
15 Ali R, Riaz A, Gabr A, Abouchaleh N, Mora R, Al Asadi A, Caicedo JC, Abecassis M, Katariya N, Maddur H, Kulik L, Lewandowski RJ, Salem R. Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection. Eur J Nucl Med Mol Imaging 2017;44:2195-202. [DOI: 10.1007/s00259-017-3792-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
16 Nia BB, Nia ES, Avery RJ, Kuo PH, Hennemeyer CT. Punctate Radiation Dermatitis of the Foot and Ankle Caused by Distal Embolization of 90Y Microspheres During Liver Directed Therapy. Clin Nucl Med 2017;42:e422-3. [PMID: 28682846 DOI: 10.1097/RLU.0000000000001751] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Jadvar H. Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment. AJR Am J Roentgenol 2017;209:277-88. [PMID: 28463538 DOI: 10.2214/AJR.17.18264] [Cited by in Crossref: 39] [Cited by in F6Publishing: 15] [Article Influence: 7.8] [Reference Citation Analysis]